Surgery Allows Patient to Live Epilepsy-Free

Surgical intervention is offering a new quality of life for some individuals living with drug-resistant epilepsy, allowing some patients to remain seizure-free for extended periods. In one such case, a 32-year-old Parisian jurist named Apolline, who had lived with the condition since age 13, reported remaining seizure-free for one year following a brain operation at the GHU de Paris (Sainte-Anne Hospital) in 2024.

Epilepsy is a complex neurological condition characterized by a wide diversity of symptoms and progressions. According to data from Santé publique France, nearly 700,000 people in France live with epilepsy, making it the third most common neurological disease in the country, following dementia and migraines.

The Impact of Drug-Resistant Epilepsy

For many, epilepsy is managed through medication. However, a significant portion of the patient population experiences what is known as drug-resistant epilepsy. While 60% to 70% of people with epilepsy see their condition controlled by medication, nearly one-third of patients remain resistant to these treatments.

The burden of the disease extends beyond the seizures themselves. Patients often face significant personal and social repercussions, as well as the side effects of long-term medication. Apolline described the experience as a weight, a burden, a source of anxiety and noted that the medications she was prescribed during her adolescence led to weight gain and dark thoughts.

Surgical Options and Efficacy

When medication fails to control seizures, surgical options may be considered. The primary goal of epilepsy surgery is typically to remove the specific area of the brain where the seizures originate. This approach can lead to a significant reduction or the complete disappearance of seizures.

Not all patients are candidates for surgery. Eligibility generally depends on whether the epilepsy is sufficiently disruptive to daily life and whether the seizure-triggering zone can be precisely identified and removed without causing unacceptable neurological deficits.

The success rate of these procedures is often linked to the underlying cause, or etiology, of the epilepsy. Research indicates that the resection of a single, well-defined lesion typically yields the highest success rates. For example, post-traumatic lesions—which account for 4% to 9% of all epilepsy cases and 20% of symptomatic epilepsy cases—are a frequent target for such interventions.

Demographics and Prevalence

The prevalence of epilepsy varies significantly across different age groups and genders. Data from Santé publique France indicates that prevalence generally increases with age:

• Men: Prevalence rises from 2.6 per 1,000 inhabitants at birth to 20 per 1,000 by age 80.
• Women: Prevalence varies from approximately 2.6 per 1,000 at birth to nearly 15 per 1,000 by age 80.
• Adolescents: The prevalence at this age is approximately 5 per 1,000 inhabitants.

Health officials note that the earlier increase in prevalence among men is primarily attributed to comorbidities, particularly cardiovascular issues such as strokes, which can trigger epilepsy and tend to occur earlier in men than in women.

Future Directions in Treatment

Beyond traditional resection surgery, medical research is exploring less invasive alternatives for those with drug-resistant epilepsy. This includes the investigation of radio-surgery as a potential new therapy, which may provide options for patients who are not candidates for traditional open-brain surgery.

For patients like Apolline, the transition from chronic illness to a seizure-free state represents a profound shift in autonomy. Following her 2024 procedure, she described herself as feeling liberated, illustrating the potential for surgical intervention to restore a sense of serenity and stability to those living with refractory epilepsy.